Literature DB >> 10751246

Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals.

F Romanelli1, H R Jennings, A Nath, M Ryan, J Berger.   

Abstract

ARTICLE ABSTRACT: The concurrent use of anticonvulsants and antiretrovirals is a poorly studied area that poses a therapeutic dilemma for the clinician caring for HIV-positive patients requiring both classes of medications. Anticonvulsants and antiretrovirals may interact through multiple mechanisms including competition for protein binding, enhanced or reduced liver metabolism, and increased viral replication. The authors present many of the challenges faced by clinicians caring for HIV-positive patients who may require anticonvulsant therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751246     DOI: 10.1212/wnl.54.7.1404

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  New antiepileptic drugs.

Authors:  C W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

2.  Safe Treatment of Seizures in the Setting of HIV/AIDS.

Authors:  Omar Siddiqi; Gretchen L Birbeck
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 3.  Seizures in HIV-seropositive individuals: epidemiology and treatment.

Authors:  Frank Romanelli; Melody Ryan
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  Clinically relevant drug interactions with antiepileptic drugs.

Authors:  Emilio Perucca
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

5.  HIV Dementia.

Authors:  Avindra Nath; Joseph Berger
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.972

6.  Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.

Authors:  Kathy Lee; Pornpun Vivithanaporn; Reed A Siemieniuk; Hartmut B Krentz; Ferdinand Maingat; M John Gill; Christopher Power
Journal:  BMC Neurol       Date:  2010-06-17       Impact factor: 2.474

7.  Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.

Authors:  Jason F Okulicz; Greg A Grandits; Jacqueline A French; Jomy M George; David M Simpson; Gretchen L Birbeck; Anuradha Ganesan; Amy C Weintrob; Nancy Crum-Cianflone; Tahaniyat Lalani; Michael L Landrum
Journal:  AIDS Res Ther       Date:  2011-05-16       Impact factor: 2.250

8.  Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era.

Authors:  Mathura Ravishankar; Ifunanya Dallah; Manoj Mathews; Christopher M Bositis; Musaku Mwenechanya; Lisa Kalungwana-Mambwe; David Bearden; Allison Navis; Melissa A Elafros; Harris Gelbard; William H Theodore; Igor J Koralnik; Jason F Okulicz; Brent A Johnson; Clara Belessiotis; Ornella Ciccone; Natalie Thornton; Melissa Tsuboyama; Omar K Siddiqi; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck
Journal:  Epilepsia Open       Date:  2022-04-01

9.  Inadequate pain relief in ambulatory patients with human immunodeficiency virus disease in Port Harcourt.

Authors:  Longinus Ndubuisi Ebirim; Job Gogo Otokwala
Journal:  HIV AIDS (Auckl)       Date:  2013-08-13

Review 10.  Role of anticonvulsants in the management of AIDS related seizures.

Authors:  Batool F Kirmani; Diana Mungall-Robinson
Journal:  Front Neurol       Date:  2014-01-30       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.